Skip to main content
CDSCO Approved (India)Prescription MedicineNot sold in the US

Pill

No non-hormonal birth control pill is FDA-approved in the US. Ormeloxifene (centchroman) is approved and used in India.

Last verified Updated Sources

Pill (Prescription Medicine)

Method facts

Pill
Effectiveness
Limited evidence
How long it lasts
Weekly pill (ongoing)
Reversibility
Reversible
STI protection
No
How you get it
Not Available in the US · Prescription required
Cost
Contact providerInsurance coverage: Varies
Status
CDSCO Approved (India)

How well it works

Limited evidence

Two Phase III trials in India reported Pearl Index values of 4.2 and 3.7 and effectiveness of 95.9% and 95.8%; effectiveness across eight published studies ranged from 93% to 100% (Kabra 2019 scoping review). Pregnancies from user failure, when the pill was not taken on schedule, were 9.4% and 10.2% in those trials. These small studies do not give typical-use or perfect-use estimates, so both are null. A 2026 systematic review (Tufa 2026) found Pearl Index values from 0.48 to 4.2 per 100 woman-years across 12 contraceptive studies, all conducted in India and all at high risk of bias.

The details

What the evidence says

How well it works, what to watch for, who should avoid it, and the studies behind it.

How it works in the body

Clinical class
Centchroman (ormeloxifene)

Ormeloxifene (centchroman) is a selective estrogen receptor modulator (SERM) that prevents pregnancy by inhibiting implantation of a fertilized egg in the endometrium. It does not appear to stop ovulation and does not contain estrogen or progestin. It is not FDA-approved in the US.

Side effects

  • Menstrual irregularities (prolonged cycles or continuous bleeding; rates varied widely across studies)
  • Headache
  • Nausea
  • Abdominal pain
  • Breast tenderness

Who shouldn't use this

No contraindications are currently listed.

Cost and insurance

Not available in the US. In India, it is distributed free of cost through the public health system under the brand name Chhaya.

Insurance coverageVaries

What to know about Pill

Why there is no non-hormonal birth control pill in the US

The birth control pills in the FDA’s birth control guide all contain hormones. Combined pills have estrogen and a progestin. Progestin-only pills have a progestin; you may need a prescription, but one version, norgestrel, is sold over the counter. The FDA guide lists no non-hormonal birth control pill.

Ormeloxifene (centchroman): a non-hormonal contraceptive pill

Ormeloxifene, also called centchroman, is a non-steroidal selective estrogen receptor modulator. India’s Central Drug Research Institute (CDRI) developed ormeloxifene, and India’s drug regulator, CDSCO, lists centchroman 30 mg tablets as approved for use as an oral contraceptive in November 1990. It is mainly thought to work on the cervical mucus and uterine lining, affecting sperm transport and implantation of a fertilized egg. It does not appear to stop ovulation, and it does not contain estrogen or progestin.

The recommended dosing schedule is 30 mg twice weekly for the first 12 weeks, then once weekly after that. In two Phase III trials in India, the Pearl Index was 4.2 and 3.7 and effectiveness was 95.9% and 95.8%; across eight published studies, effectiveness ranged from 93% to 100%. Pregnancies from user failure, when the pill was not taken on schedule, were 9.4% and 10.2% in those two trials. These small studies do not give a typical-use rate, so this page lists none. A 2026 systematic review found that all 14 studies of ormeloxifene for contraception were conducted in India and had a high risk of bias.

The most commonly reported side effects are menstrual changes, such as prolonged cycles and continuous bleeding, and reported rates varied widely between studies. Other reported side effects include headache, nausea, abdominal pain, and breast tenderness. This page does not list contraindications, because we could not find a current official prescribing label for ormeloxifene to cite.

Closest US alternatives

If you want non-hormonal birth control in the US, the available methods are not pills. They include the copper IUD, a prescription vaginal pH modulator gel, barrier methods (condoms, diaphragm, cervical cap, spermicide), fertility awareness apps, and sterilization for women and men. Check our provider directory for clinics near you that can discuss non-hormonal alternatives.

Frequently asked questions

Sources (10)
  1. Research source: Kabra R et al. 2019, BMJ Open scoping review of centchroman/ormeloxifene evidence (PMID 31594884)
  2. Research source: Singh MM, 2001, Medicinal Research Reviews — centchroman as a contraceptive and for hormone-related disorders (PMID 11410933)
  3. Research source: Kabra R et al. 2019, BMJ Open scoping review, full text (PMC6797402)
  4. Research source: Tufa T et al. 2026, BMJ Sex Reprod Health — Contraceptive effectiveness and safety of ormeloxifene: a systematic review (PMID 42778303)
  5. Research source: CDSCO — List of new drugs approved in India, 1981-1990 (centchroman 30 mg tablet, November 1990)
  6. Research source: Mokkarala S et al. 2025, Contraception — scoping review of approved contraceptive methods not in the WHO MEC, full text (PMC12592015)
  7. Research source: FDA — Birth control guide
  8. Research source: DailyMed — Phexxi (lactic acid, citric acid, and potassium bitartrate) vaginal gel FDA label
  9. Research source: WHO — Family planning/contraception methods fact sheet
  10. Research source: Medical Dialogues — Centchroman (ormeloxifene) drug information (prescription status in India)

How we verify